51 – 60 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Familial risks of breast and prostate cancers: Does the definition of the at risk period matter?
(
- Contribution to journal › Article
-
Mark
Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema (BCRL). Proposals from an expert group
(
- Contribution to journal › Article
-
Mark
Diagnostic work-up of contralateral breast cancers has not improved over calendar period
(
- Contribution to journal › Article
- 2009
-
Mark
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma
(
- Contribution to journal › Article
- 2008
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article
-
Mark
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations : a case-control study
(
- Contribution to journal › Article
- 2007
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
-
Mark
High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort
(
- Contribution to journal › Article
- 2006
-
Mark
Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding